Haodong Cai

1095 Jiefang Avenue
Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

CD19 chimeric antigen receptor T-cell therapy for the treatment of a patient with refractory Burkitt lymphoma after kidney transplant.

CD19 chimeric antigen receptor T-cell therapy for the treatment of a patient with refractory Burkitt lymphoma after kidney transplant.

Journal: Cytotherapy
Published: June 02, 2025

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia.

Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia.

Journal: Cancer immunology, immunotherapy : CII
Published: December 08, 2022

Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis.

Detection of cytomegalovirus (CMV) by digital PCR in stool samples for the non-invasive diagnosis of CMV gastroenteritis.

Journal: Virology journal
Published: July 16, 2022

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy.

A Model Perspective Explanation of the Long-Term Sustainability of a Fully Human BCMA-Targeting CAR (CT103A) T-Cell Immunotherapy.

Journal: Frontiers in pharmacology
Published: October 28, 2021

A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.

A novel diagnostic approach for the classification of small B-cell lymphoid neoplasms based on the NanoString platform.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 09, 2021

The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage.

The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage.

Journal: Scientific reports
Published: March 24, 2021

A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL.

A novel full-human CD22-CAR T cell therapy with potent activity against CD22low B-ALL.

Journal: Blood cancer journal
Published: January 21, 2021

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma.

A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma.

Journal: Blood
Published: September 09, 2020

The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.

The utility of non-invasive liquid biopsy for mutational analysis and minimal residual disease assessment in extramedullary multiple myeloma.

Journal: British journal of haematology
Published: March 20, 2020

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia.

Journal: Cancer medicine
Published: December 21, 2019

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.

Journal: Blood
Published: February 01, 2019

A rare e14a3 BCR/ABL fusion transcript in acute lymphoblastic leukemia patient treated with CAR-modified T-cell therapy.

A rare e14a3 BCR/ABL fusion transcript in acute lymphoblastic leukemia patient treated with CAR-modified T-cell therapy.

Journal: Oncology letters
Published: August 08, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026